Education
About Us
Working with TipRanks
Follow Us
BioLargo Inc (BLGO)
OTHER OTC:BLGO
Earnings Data
Report Date
May 20, 2026TBA (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.01Last Year’s EPS
>-0.01Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call balanced notable commercialization and validation milestones (Clyra launch and clinical data, AEC municipal install with EPA monitoring, Cellinity MOUs and technology validation, service revenue doubling, and preserved cash) against material near-term financial challenges (2025 revenue decline to $7.8M, $15.2M net loss, a booked credit loss, Pooph license termination and litigation, and diminished shareholders' equity). Management emphasizes transition from development to commercialization and several near-term catalysts for 2026, but the significant 2025 financial deterioration and ongoing legal/partner risks temper the outlook.Company Guidance
Clyra Medical Commercial Launch and Clinical Validation
ViaCLYR (Clyra Medical) is now in commercial stage with FDA 510(k) clearance, an exclusive distribution agreement with Advanced Solution, and the first commercial stocking order shipped and paid. Strong clinical data was presented at the 48th Annual Boswick Symposium. Recent capital infusion of $1.7M (received in the last few weeks) positions Clyra for revenue growth; direct investments into Clyra over the past ~14 months total about $7.5M, with BioLargo contributing ~ $1.7M over the last 2 years and insiders (CEO and Chairman) contributing ~ $320k.
AEC PFAS Technology Field Validation and Regulatory Engagement
First municipal deployment of the AEC system installed at Lake Stockholm, NJ, now under a 12-month monitoring program with the U.S. EPA and New Jersey Department of Environmental Protection. Company reports AEC treats long-, short- and ultra-short-chain PFAS with minimal waste; EPA engagement signals regulatory validation and potential broader adoption.
Cellinity Battery Progress and Market Opportunity
Cellinity liquid-sodium battery technology described as technically de-risked with third-party validation and 4 signed MOUs; actively negotiating joint-venture gigafactory partnerships. Management projects each gigafactory could generate approximately $80M–$90M annual net operating income on an estimated ~$170M capital investment. Key technology attributes: 20-year life, no thermal runaway risk, and use of earth-abundant materials.
Service Revenue Growth and Maintained Liquidity
Service revenues roughly doubled year-over-year from $1.0M to approximately $2.0M (≈+100%), demonstrating organic growth in engineering and services. The company maintained liquidity throughout 2025, ending the year with $3.9M in cash and access to capital markets without issuing 'toxic debt'.
Corporate Model and Recurring Revenue Potential
BioLargo holds significant equity stakes (49%–100%) across four platforms and earns a 6% royalty on subsidiary sales, creating a diversified investment structure intended to de-risk the corporate balance sheet while preserving upside from multiple commercialization catalysts across medical, water treatment, battery and environmental product businesses.
BLGO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BLGO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 05, 2026 | $0.18 | $0.17 | -5.59% |
Nov 17, 2025 | $0.16 | $0.16 | 0.00% |
Aug 15, 2025 | $0.18 | $0.18 | -4.35% |
May 15, 2025 | $0.24 | $0.24 | -2.05% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does BioLargo Inc (BLGO) report earnings?
BioLargo Inc (BLGO) is schdueled to report earning on May 20, 2026, TBA (Confirmed).
What is BioLargo Inc (BLGO) earnings time?
BioLargo Inc (BLGO) earnings time is at May 20, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BLGO EPS forecast?
BLGO EPS forecast for the fiscal quarter 2026 (Q1) is -0.01.